2.要約四半期連結財務諸表及び主な注記
(1)要約四半期連結純損益計算書
| | | |
| | | (単位:百万円) |
| 前第1四半期連結累計期間 (自 2018年4月1日 至 2018年6月30日) | | 当第1四半期連結累計期間 (自 2019年4月1日 至 2019年6月30日) |
売上収益 | 329,085 | | 334,134 |
売上原価 | △70,736 | | △70,512 |
売上総利益 | 258,349 | | 263,622 |
| | | |
販売費及び一般管理費 | △112,888 | | △117,470 |
研究開発費 | △52,132 | | △53,507 |
無形資産償却費 | △9,039 | | △7,178 |
持分法による投資損益 | △252 | | △728 |
その他の収益 | 4,239 | | 4,522 |
その他の費用 | △24,728 | | △12,174 |
営業利益 | 63,548 | | 77,086 |
| | | |
金融収益 | 1,166 | | 766 |
金融費用 | △219 | | △1,325 |
税引前四半期利益 | 64,495 | | 76,528 |
法人所得税費用 | △9,935 | | △18,010 |
四半期利益 | 54,559 | | 58,518 |
| | | |
四半期利益の帰属 | | | |
親会社の所有者 | 54,559 | | 58,518 |
| | | |
1株当たり四半期利益 | | | |
基本的1株当たり四半期利益(円) | 27.68 | | 31.03 |
希薄化後1株当たり四半期利益(円) | 27.65 | | 31.00 |
E0092045030アステラス製薬株式会社Astellas Pharma Inc.四半期第3号参考様式 [IFRS](連結)IFRStrueCTE2019-04-012019-06-30Q12020-03-312018-04-012018-06-302019-03-311falsefalsefalse450302019-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302019-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember450302019-06-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302019-06-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302019-06-30jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302019-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302019-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember450302019-06-30jpigp_cor:RetainedEarningsIFRSMember450302019-06-30jpigp_cor:TreasurySharesIFRSMember450302019-06-30jpigp_cor:CapitalSurplusIFRSMember450302019-06-30jpigp_cor:ShareCapitalIFRSMember450302019-04-012019-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302019-04-012019-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember450302019-04-012019-06-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302019-04-012019-06-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302019-04-012019-06-30jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302019-04-012019-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302019-04-012019-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember450302019-04-012019-06-30jpigp_cor:RetainedEarningsIFRSMember450302019-04-012019-06-30jpigp_cor:TreasurySharesIFRSMember450302019-04-012019-06-30jpigp_cor:CapitalSurplusIFRSMember450302019-04-012019-06-30jpigp_cor:ShareCapitalIFRSMember450302019-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302019-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember450302019-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302019-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302019-03-31jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302019-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302019-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember450302019-03-31jpigp_cor:RetainedEarningsIFRSMember450302019-03-31jpigp_cor:TreasurySharesIFRSMember450302019-03-31jpigp_cor:CapitalSurplusIFRSMember450302019-03-31jpigp_cor:ShareCapitalIFRSMember450302018-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302018-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember450302018-06-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302018-06-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302018-06-30jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302018-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302018-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember450302018-06-30jpigp_cor:RetainedEarningsIFRSMember450302018-06-30jpigp_cor:TreasurySharesIFRSMember450302018-06-30jpigp_cor:CapitalSurplusIFRSMember450302018-06-30jpigp_cor:ShareCapitalIFRSMember450302018-04-012018-06-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302018-04-012018-06-30jpigp_cor:OtherComponentsOfEquityIFRSMember450302018-04-012018-06-30jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302018-04-012018-06-30jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302018-04-012018-06-30jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302018-04-012018-06-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302018-04-012018-06-30jpigp_cor:ShareAcquisitionRightsIFRSMember450302018-04-012018-06-30jpigp_cor:RetainedEarningsIFRSMember450302018-04-012018-06-30jpigp_cor:TreasurySharesIFRSMember450302018-04-012018-06-30jpigp_cor:CapitalSurplusIFRSMember450302018-04-012018-06-30jpigp_cor:ShareCapitalIFRSMember450302018-03-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember450302018-03-31jpigp_cor:OtherComponentsOfEquityIFRSMember450302018-03-31jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember450302018-03-31jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember450302018-03-31jpigp_cor:ChangeInFairValueOfAvailableForSaleFinancialAssetsIFRSMember450302018-03-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember450302018-03-31jpigp_cor:ShareAcquisitionRightsIFRSMember450302018-03-31jpigp_cor:RetainedEarningsIFRSMember450302018-03-31jpigp_cor:TreasurySharesIFRSMember450302018-03-31jpigp_cor:CapitalSurplusIFRSMember450302018-03-31jpigp_cor:ShareCapitalIFRSMember450302018-03-31450302019-07-30450302019-06-30450302018-06-30450302018-04-012018-06-30450302019-03-31450302019-04-012019-06-30iso4217:JPYxbrli:sharesxbrli:pureiso4217:JPY